# EDGAR Filing Document

**Accession Number:** 0001281446
**File Stem:** 0001172661-25-004069
**Filing Date:** 2025-8
**Character Count:** 70723
**Document Hash:** 3e768183daa9f25d769364ddb7220b6b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001172661-25-004069.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001172661-25-004069

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GREAT POINT PARTNERS LLC
- **CENTRAL INDEX KEY:** 0001281446

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-11743
- **FILM NUMBER:** 251280744

**BUSINESS ADDRESS:**
- **STREET 1:** 165 MASON STREET, 3RD FLOOR
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 203 971-3300

**MAIL ADDRESS:**
- **STREET 1:** 165 MASON STREET, 3RD FLOOR
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001281446

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** GREAT POINT PARTNERS LLC

**Address:** 165 MASON STREET, 3RD FLOOR, GREENWICH, CT 06830

**Telephone number:** 203-971-3300

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-11743

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 2

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                   | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                              | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| ABIVAX SA                        | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         523538 |                0 | FOR         |                                   523538 | FOR                         |  |
| ABIVAX SA                        | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         523538 |                0 | FOR         |                                   523538 | FOR                         |  |
| ABIVAX SA                        | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        1062940 |                0 | FOR         |                                  1062940 | FOR                         |  |
| ABIVAX SA                        | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        1062940 |                0 | FOR         |                                  1062940 | FOR                         |  |
| ABIVAX SA                        | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         523538 |                0 | FOR         |                                   523538 | FOR                         |  |
| ABIVAX SA                        | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         523538 |                0 | FOR         |                                   523538 | FOR                         |  |
| ABIVAX SA                        | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        1062940 |                0 | FOR         |                                  1062940 | FOR                         |  |
| ABIVAX SA                        | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        1062940 |                0 | FOR         |                                  1062940 | FOR                         |  |
| AKEBIA THERAPEUTICS, INC.        | 00972D105 | 06/10/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement.                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        1641367 |                0 | FOR         |                                  1641367 | FOR                         |  |
| AKEBIA THERAPEUTICS, INC.        | 00972D105 | 06/10/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement.                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        3332473 |                0 | FOR         |                                  3332473 | FOR                         |  |
| AKEBIA THERAPEUTICS, INC.        | 00972D105 | 06/10/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement.                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        1641367 |                0 | FOR         |                                  1641367 | FOR                         |  |
| AKEBIA THERAPEUTICS, INC.        | 00972D105 | 06/10/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement.                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        3332473 |                0 | FOR         |                                  3332473 | FOR                         |  |
| AKERO THERAPEUTICS, INC          | 00973Y108 | 06/03/2025     | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |             10 |                0 | FOR         |                                       10 | FOR                         |  |
| AKERO THERAPEUTICS, INC          | 00973Y108 | 06/03/2025     | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          38109 |                0 | FOR         |                                    38109 | FOR                         |  |
| AKERO THERAPEUTICS, INC          | 00973Y108 | 06/03/2025     | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |             10 |                0 | FOR         |                                       10 | FOR                         |  |
| AKERO THERAPEUTICS, INC          | 00973Y108 | 06/03/2025     | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          38109 |                0 | FOR         |                                    38109 | FOR                         |  |
| AMYLYX PHARMACEUTICALS, INC.     | 03237H101 | 06/05/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         660000 |                0 | ABSTAIN     |                                   660000 | AGAINST                     |  |
| AMYLYX PHARMACEUTICALS, INC.     | 03237H101 | 06/05/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |        1340000 |                0 | ABSTAIN     |                                  1340000 | AGAINST                     |  |
| AMYLYX PHARMACEUTICALS, INC.     | 03237H101 | 06/05/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         660000 |                0 | ABSTAIN     |                                   660000 | AGAINST                     |  |
| AMYLYX PHARMACEUTICALS, INC.     | 03237H101 | 06/05/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |        1340000 |                0 | ABSTAIN     |                                  1340000 | AGAINST                     |  |
| ARCELLX, INC.                    | 03940C100 | 05/28/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.                                                                                          | SECTION 14A SAY-ON-PAY VOTES |             54 |                0 | FOR         |                                       54 | FOR                         |  |
| ARCELLX, INC.                    | 03940C100 | 05/28/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.                                                                                          | SECTION 14A SAY-ON-PAY VOTES |            110 |                0 | FOR         |                                      110 | FOR                         |  |
| ARCELLX, INC.                    | 03940C100 | 05/28/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.                                                                                          | SECTION 14A SAY-ON-PAY VOTES |             54 |                0 | FOR         |                                       54 | FOR                         |  |
| ARCELLX, INC.                    | 03940C100 | 05/28/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.                                                                                          | SECTION 14A SAY-ON-PAY VOTES |            110 |                0 | FOR         |                                      110 | FOR                         |  |
| AUTOLUS THERAPEUTICS PLC         | 05280R100 | 06/26/2025     | To approve the Directors' remuneration report (excluding the Directors' remuneration policy set out on pages 39 to 52 of Directors' remuneration report), which is set out on pages 36 to 65 of the 2024 Annual Report and Accounts.                                                          | SECTION 14A SAY-ON-PAY VOTES |         242635 |                0 | FOR         |                                   242635 | FOR                         |  |
| AUTOLUS THERAPEUTICS PLC         | 05280R100 | 06/26/2025     | To approve the Directors' remuneration report (excluding the Directors' remuneration policy set out on pages 39 to 52 of Directors' remuneration report), which is set out on pages 36 to 65 of the 2024 Annual Report and Accounts.                                                          | SECTION 14A SAY-ON-PAY VOTES |         492622 |                0 | FOR         |                                   492622 | FOR                         |  |
| AUTOLUS THERAPEUTICS PLC         | 05280R100 | 06/26/2025     | To approve the Directors' remuneration report (excluding the Directors' remuneration policy set out on pages 39 to 52 of Directors' remuneration report), which is set out on pages 36 to 65 of the 2024 Annual Report and Accounts.                                                          | SECTION 14A SAY-ON-PAY VOTES |         242635 |                0 | FOR         |                                   242635 | FOR                         |  |
| AUTOLUS THERAPEUTICS PLC         | 05280R100 | 06/26/2025     | To approve the Directors' remuneration report (excluding the Directors' remuneration policy set out on pages 39 to 52 of Directors' remuneration report), which is set out on pages 36 to 65 of the 2024 Annual Report and Accounts.                                                          | SECTION 14A SAY-ON-PAY VOTES |         492622 |                0 | FOR         |                                   492622 | FOR                         |  |
| BEAM THERAPEUTICS INC.           | 07373V105 | 06/04/2025     | Approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          61447 |                0 | FOR         |                                    61447 | FOR                         |  |
| BEAM THERAPEUTICS INC.           | 07373V105 | 06/04/2025     | Approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         114115 |                0 | FOR         |                                   114115 | FOR                         |  |
| BEAM THERAPEUTICS INC.           | 07373V105 | 06/04/2025     | Approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          61447 |                0 | FOR         |                                    61447 | FOR                         |  |
| BEAM THERAPEUTICS INC.           | 07373V105 | 06/04/2025     | Approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         114115 |                0 | FOR         |                                   114115 | FOR                         |  |
| CYTOKINETICS, INCORPORATED       | 23282W605 | 05/14/2025     | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         129500 |                0 | FOR         |                                   129500 | FOR                         |  |
| CYTOKINETICS, INCORPORATED       | 23282W605 | 05/14/2025     | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         240500 |                0 | FOR         |                                   240500 | FOR                         |  |
| CYTOKINETICS, INCORPORATED       | 23282W605 | 05/14/2025     | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         129500 |                0 | FOR         |                                   129500 | FOR                         |  |
| CYTOKINETICS, INCORPORATED       | 23282W605 | 05/14/2025     | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         240500 |                0 | FOR         |                                   240500 | FOR                         |  |
| DBV TECHNOLOGIES S.A.            | 23306J309 | 06/11/2025     | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          72537 |                0 | FOR         |                                    72537 | FOR                         |  |
| DBV TECHNOLOGIES S.A.            | 23306J309 | 06/11/2025     | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          72537 |                0 | FOR         |                                    72537 | FOR                         |  |
| DBV TECHNOLOGIES S.A.            | 23306J309 | 06/11/2025     | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          72537 |                0 | FOR         |                                    72537 | FOR                         |  |
| DBV TECHNOLOGIES S.A.            | 23306J309 | 06/11/2025     | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         147272 |                0 | FOR         |                                   147272 | FOR                         |  |
| DBV TECHNOLOGIES S.A.            | 23306J309 | 06/11/2025     | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         147272 |                0 | FOR         |                                   147272 | FOR                         |  |
| DBV TECHNOLOGIES S.A.            | 23306J309 | 06/11/2025     | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         147272 |                0 | FOR         |                                   147272 | FOR                         |  |
| DBV TECHNOLOGIES S.A.            | 23306J309 | 06/11/2025     | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          72537 |                0 | FOR         |                                    72537 | FOR                         |  |
| DBV TECHNOLOGIES S.A.            | 23306J309 | 06/11/2025     | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          72537 |                0 | FOR         |                                    72537 | FOR                         |  |
| DBV TECHNOLOGIES S.A.            | 23306J309 | 06/11/2025     | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          72537 |                0 | FOR         |                                    72537 | FOR                         |  |
| DBV TECHNOLOGIES S.A.            | 23306J309 | 06/11/2025     | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         147272 |                0 | FOR         |                                   147272 | FOR                         |  |
| DBV TECHNOLOGIES S.A.            | 23306J309 | 06/11/2025     | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         147272 |                0 | FOR         |                                   147272 | FOR                         |  |
| DBV TECHNOLOGIES S.A.            | 23306J309 | 06/11/2025     | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting.                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         147272 |                0 | FOR         |                                   147272 | FOR                         |  |
| DBV TECHNOLOGIES SA              | F2927N109 | 06/11/2025     | APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND, PAID DURING THE FINANCIAL YEAR 2024 OR AWARDED FOR THE SAME FINANCIAL YEAR TO MR. MICHEL DE ROSEN, CHAIRMAN OF THE BOARD OF DIRECTORS                                     | SECTION 14A SAY-ON-PAY VOTES |         451809 |                0 | FOR         |                                   451809 | FOR                         |  |
| DBV TECHNOLOGIES SA              | F2927N109 | 06/11/2025     | APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND, PAID DURING THE FINANCIAL YEAR 2024 OR AWARDED FOR THE SAME FINANCIAL YEAR TO MR. DANIEL TASSE, CHIEF EXECUTIVE OFFICER                                                   | SECTION 14A SAY-ON-PAY VOTES |         451809 |                0 | FOR         |                                   451809 | FOR                         |  |
| DBV TECHNOLOGIES SA              | F2927N109 | 06/11/2025     | CONSULTATIVE OPINION ON THE REMUNERATION OF EXECUTIVE MANAGERS 'NAMED EXECUTIVE OFFICERS' OTHER THAN THE CHIEF EXECUTIVE OFFICER                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         451809 |                0 | FOR         |                                   451809 | FOR                         |  |
| DBV TECHNOLOGIES SA              | F2927N109 | 06/11/2025     | APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND, PAID DURING THE FINANCIAL YEAR 2024 OR AWARDED FOR THE SAME FINANCIAL YEAR TO MR. MICHEL DE ROSEN, CHAIRMAN OF THE BOARD OF DIRECTORS                                     | SECTION 14A SAY-ON-PAY VOTES |         917313 |                0 | FOR         |                                   917313 | FOR                         |  |
| DBV TECHNOLOGIES SA              | F2927N109 | 06/11/2025     | APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND, PAID DURING THE FINANCIAL YEAR 2024 OR AWARDED FOR THE SAME FINANCIAL YEAR TO MR. DANIEL TASSE, CHIEF EXECUTIVE OFFICER                                                   | SECTION 14A SAY-ON-PAY VOTES |         917313 |                0 | FOR         |                                   917313 | FOR                         |  |
| DBV TECHNOLOGIES SA              | F2927N109 | 06/11/2025     | CONSULTATIVE OPINION ON THE REMUNERATION OF EXECUTIVE MANAGERS 'NAMED EXECUTIVE OFFICERS' OTHER THAN THE CHIEF EXECUTIVE OFFICER                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         917313 |                0 | FOR         |                                   917313 | FOR                         |  |
| DBV TECHNOLOGIES SA              | F2927N109 | 06/11/2025     | APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND, PAID DURING THE FINANCIAL YEAR 2024 OR AWARDED FOR THE SAME FINANCIAL YEAR TO MR. MICHEL DE ROSEN, CHAIRMAN OF THE BOARD OF DIRECTORS                                     | SECTION 14A SAY-ON-PAY VOTES |         451809 |                0 | FOR         |                                   451809 | FOR                         |  |
| DBV TECHNOLOGIES SA              | F2927N109 | 06/11/2025     | APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND, PAID DURING THE FINANCIAL YEAR 2024 OR AWARDED FOR THE SAME FINANCIAL YEAR TO MR. DANIEL TASSE, CHIEF EXECUTIVE OFFICER                                                   | SECTION 14A SAY-ON-PAY VOTES |         451809 |                0 | FOR         |                                   451809 | FOR                         |  |
| DBV TECHNOLOGIES SA              | F2927N109 | 06/11/2025     | CONSULTATIVE OPINION ON THE REMUNERATION OF EXECUTIVE MANAGERS 'NAMED EXECUTIVE OFFICERS' OTHER THAN THE CHIEF EXECUTIVE OFFICER                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         451809 |                0 | FOR         |                                   451809 | FOR                         |  |
| DBV TECHNOLOGIES SA              | F2927N109 | 06/11/2025     | APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND, PAID DURING THE FINANCIAL YEAR 2024 OR AWARDED FOR THE SAME FINANCIAL YEAR TO MR. MICHEL DE ROSEN, CHAIRMAN OF THE BOARD OF DIRECTORS                                     | SECTION 14A SAY-ON-PAY VOTES |         917313 |                0 | FOR         |                                   917313 | FOR                         |  |
| DBV TECHNOLOGIES SA              | F2927N109 | 06/11/2025     | APPROVAL OF THE FIXED, VARIABLE AND EXCEPTIONAL ELEMENTS MAKING UP THE TOTAL REMUNERATION AND BENEFITS OF ANY KIND, PAID DURING THE FINANCIAL YEAR 2024 OR AWARDED FOR THE SAME FINANCIAL YEAR TO MR. DANIEL TASSE, CHIEF EXECUTIVE OFFICER                                                   | SECTION 14A SAY-ON-PAY VOTES |         917313 |                0 | FOR         |                                   917313 | FOR                         |  |
| DBV TECHNOLOGIES SA              | F2927N109 | 06/11/2025     | CONSULTATIVE OPINION ON THE REMUNERATION OF EXECUTIVE MANAGERS 'NAMED EXECUTIVE OFFICERS' OTHER THAN THE CHIEF EXECUTIVE OFFICER                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         917313 |                0 | FOR         |                                   917313 | FOR                         |  |
| DIANTHUS THERAPEUTICS, INC.      | 252828108 | 05/22/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          96250 |                0 | FOR         |                                    96250 | FOR                         |  |
| DIANTHUS THERAPEUTICS, INC.      | 252828108 | 05/22/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         178750 |                0 | FOR         |                                   178750 | FOR                         |  |
| DIANTHUS THERAPEUTICS, INC.      | 252828108 | 05/22/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          96250 |                0 | FOR         |                                    96250 | FOR                         |  |
| DIANTHUS THERAPEUTICS, INC.      | 252828108 | 05/22/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         178750 |                0 | FOR         |                                   178750 | FOR                         |  |
| DYNAVAX TECHNOLOGIES CORPORATION | 268158201 | 06/11/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         110319 |                0 | ABSTAIN     |                                   110319 | AGAINST                     |  |
| DYNAVAX TECHNOLOGIES CORPORATION | 268158201 | 06/11/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         223981 |                0 | ABSTAIN     |                                   223981 | AGAINST                     |  |
| DYNAVAX TECHNOLOGIES CORPORATION | 268158201 | 06/11/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         110319 |                0 | ABSTAIN     |                                   110319 | AGAINST                     |  |
| DYNAVAX TECHNOLOGIES CORPORATION | 268158201 | 06/11/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         223981 |                0 | ABSTAIN     |                                   223981 | AGAINST                     |  |
| EVOLUS, INC.                     | 30052C107 | 06/05/2025     | Approval of, on an advisory basis, the compensation of Evolus' named executive officers.                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         255879 |                0 | FOR         |                                   255879 | FOR                         |  |
| EVOLUS, INC.                     | 30052C107 | 06/05/2025     | Approval of, on an advisory basis, the compensation of Evolus' named executive officers.                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         519512 |                0 | FOR         |                                   519512 | FOR                         |  |
| EVOLUS, INC.                     | 30052C107 | 06/05/2025     | Approval of, on an advisory basis, the compensation of Evolus' named executive officers.                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         255879 |                0 | FOR         |                                   255879 | FOR                         |  |
| EVOLUS, INC.                     | 30052C107 | 06/05/2025     | Approval of, on an advisory basis, the compensation of Evolus' named executive officers.                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         519512 |                0 | FOR         |                                   519512 | FOR                         |  |
| INVENTIVA SA                     | F5R343107 | 05/22/2025     | DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. MARK PRUZANSKI AS CHAIRMAN OF THE BOARD OF DIRECTORS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024 (AS OF 13 DECEMBER 2024)                                                                               | SECTION 14A SAY-ON-PAY VOTES |        2443456 |                0 | FOR         |                                  2443456 | FOR                         |  |
| INVENTIVA SA                     | F5R343107 | 05/22/2025     | DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. FREDERIC CREN IN HIS CAPACITY AS CHAIRMAN AND CHIEF EXECUTIVE OFFICER UNTIL 13 DECEMBER 2024 AND AS CHIEF EXECUTIVE OFFICER FROM 13 DECEMBER 2024 IN RESPECT OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2024 | SECTION 14A SAY-ON-PAY VOTES |        2443456 |                0 | FOR         |                                  2443456 | FOR                         |  |
| INVENTIVA SA                     | F5R343107 | 05/22/2025     | DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. PIERRE BROQUA IN HIS CAPACITY AS DEPUTY CHIEF EXECUTIVE OFFICER FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        2443456 |                0 | FOR         |                                  2443456 | FOR                         |  |
| INVENTIVA SA                     | F5R343107 | 05/22/2025     | DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. MARK PRUZANSKI AS CHAIRMAN OF THE BOARD OF DIRECTORS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024 (AS OF 13 DECEMBER 2024)                                                                               | SECTION 14A SAY-ON-PAY VOTES |        4960957 |                0 | FOR         |                                  4960957 | FOR                         |  |
| INVENTIVA SA                     | F5R343107 | 05/22/2025     | DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. FREDERIC CREN IN HIS CAPACITY AS CHAIRMAN AND CHIEF EXECUTIVE OFFICER UNTIL 13 DECEMBER 2024 AND AS CHIEF EXECUTIVE OFFICER FROM 13 DECEMBER 2024 IN RESPECT OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2024 | SECTION 14A SAY-ON-PAY VOTES |        4960957 |                0 | FOR         |                                  4960957 | FOR                         |  |
| INVENTIVA SA                     | F5R343107 | 05/22/2025     | DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. PIERRE BROQUA IN HIS CAPACITY AS DEPUTY CHIEF EXECUTIVE OFFICER FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        4960957 |                0 | FOR         |                                  4960957 | FOR                         |  |
| INVENTIVA SA                     | F5R343107 | 05/22/2025     | DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. MARK PRUZANSKI AS CHAIRMAN OF THE BOARD OF DIRECTORS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024 (AS OF 13 DECEMBER 2024)                                                                               | SECTION 14A SAY-ON-PAY VOTES |        2443456 |                0 | FOR         |                                  2443456 | FOR                         |  |
| INVENTIVA SA                     | F5R343107 | 05/22/2025     | DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. FREDERIC CREN IN HIS CAPACITY AS CHAIRMAN AND CHIEF EXECUTIVE OFFICER UNTIL 13 DECEMBER 2024 AND AS CHIEF EXECUTIVE OFFICER FROM 13 DECEMBER 2024 IN RESPECT OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2024 | SECTION 14A SAY-ON-PAY VOTES |        2443456 |                0 | FOR         |                                  2443456 | FOR                         |  |
| INVENTIVA SA                     | F5R343107 | 05/22/2025     | DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. PIERRE BROQUA IN HIS CAPACITY AS DEPUTY CHIEF EXECUTIVE OFFICER FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        2443456 |                0 | FOR         |                                  2443456 | FOR                         |  |
| INVENTIVA SA                     | F5R343107 | 05/22/2025     | DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. MARK PRUZANSKI AS CHAIRMAN OF THE BOARD OF DIRECTORS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024 (AS OF 13 DECEMBER 2024)                                                                               | SECTION 14A SAY-ON-PAY VOTES |        4960957 |                0 | FOR         |                                  4960957 | FOR                         |  |
| INVENTIVA SA                     | F5R343107 | 05/22/2025     | DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. FREDERIC CREN IN HIS CAPACITY AS CHAIRMAN AND CHIEF EXECUTIVE OFFICER UNTIL 13 DECEMBER 2024 AND AS CHIEF EXECUTIVE OFFICER FROM 13 DECEMBER 2024 IN RESPECT OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2024 | SECTION 14A SAY-ON-PAY VOTES |        4960957 |                0 | FOR         |                                  4960957 | FOR                         |  |
| INVENTIVA SA                     | F5R343107 | 05/22/2025     | DEFINITIVE APPROVAL OF THE FIXED AND VARIABLE REMUNERATION PAID OR ALLOCATED TO MR. PIERRE BROQUA IN HIS CAPACITY AS DEPUTY CHIEF EXECUTIVE OFFICER FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        4960957 |                0 | FOR         |                                  4960957 | FOR                         |  |
| IONIS PHARMACEUTICALS, INC.      | 462222100 | 06/05/2025     | To make an advisory vote on executive compensation.                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          33000 |                0 | FOR         |                                    33000 | FOR                         |  |
| IONIS PHARMACEUTICALS, INC.      | 462222100 | 06/05/2025     | To make an advisory vote on executive compensation.                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          67000 |                0 | FOR         |                                    67000 | FOR                         |  |
| IONIS PHARMACEUTICALS, INC.      | 462222100 | 06/05/2025     | To make an advisory vote on executive compensation.                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          33000 |                0 | FOR         |                                    33000 | FOR                         |  |
| IONIS PHARMACEUTICALS, INC.      | 462222100 | 06/05/2025     | To make an advisory vote on executive compensation.                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          67000 |                0 | FOR         |                                    67000 | FOR                         |  |
| KALVISTA PHARMACEUTICALS, INC.   | 483497103 | 10/03/2024     | Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         526121 |                0 | FOR         |                                   526121 | FOR                         |  |
| KALVISTA PHARMACEUTICALS, INC.   | 483497103 | 10/03/2024     | Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         764258 |                0 | FOR         |                                   764258 | FOR                         |  |
| KALVISTA PHARMACEUTICALS, INC.   | 483497103 | 10/03/2024     | Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         526121 |                0 | FOR         |                                   526121 | FOR                         |  |
| KALVISTA PHARMACEUTICALS, INC.   | 483497103 | 10/03/2024     | Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         764258 |                0 | FOR         |                                   764258 | FOR                         |  |
| MEREO BIOPHARMA GROUP PLC        | 589492107 | 05/13/2025     | That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         363003 |                0 | FOR         |                                   363003 | FOR                         |  |
| MEREO BIOPHARMA GROUP PLC        | 589492107 | 05/13/2025     | That the frequency of future advisory votes on the compensation of the Company's named executive officers be approved, on an advisory (nonbinding) basis.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         363003 |                0 | ABSTAIN     |                                   363003 | AGAINST                     |  |
| MEREO BIOPHARMA GROUP PLC        | 589492107 | 05/13/2025     | That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         737015 |                0 | FOR         |                                   737015 | FOR                         |  |
| MEREO BIOPHARMA GROUP PLC        | 589492107 | 05/13/2025     | That the frequency of future advisory votes on the compensation of the Company's named executive officers be approved, on an advisory (nonbinding) basis.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         737015 |                0 | ABSTAIN     |                                   737015 | AGAINST                     |  |
| MEREO BIOPHARMA GROUP PLC        | 589492107 | 05/13/2025     | That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         363003 |                0 | FOR         |                                   363003 | FOR                         |  |
| MEREO BIOPHARMA GROUP PLC        | 589492107 | 05/13/2025     | That the frequency of future advisory votes on the compensation of the Company's named executive officers be approved, on an advisory (nonbinding) basis.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         363003 |                0 | ABSTAIN     |                                   363003 | AGAINST                     |  |
| MEREO BIOPHARMA GROUP PLC        | 589492107 | 05/13/2025     | That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         737015 |                0 | FOR         |                                   737015 | FOR                         |  |
| MEREO BIOPHARMA GROUP PLC        | 589492107 | 05/13/2025     | That the frequency of future advisory votes on the compensation of the Company's named executive officers be approved, on an advisory (nonbinding) basis.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         737015 |                0 | ABSTAIN     |                                   737015 | AGAINST                     |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          80229 |                0 | FOR         |                                    80229 | FOR                         |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         177550 |                0 | FOR         |                                   177550 | FOR                         |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          80229 |                0 | FOR         |                                    80229 | FOR                         |  |
| MERUS N.V.                       | N5749R100 | 05/21/2025     | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         177550 |                0 | FOR         |                                   177550 | FOR                         |  |
| NEUROGENE INC.                   | 64135M105 | 06/12/2025     | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         162291 |                0 | FOR         |                                   162291 | FOR                         |  |
| NEUROGENE INC.                   | 64135M105 | 06/12/2025     | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         329501 |                0 | FOR         |                                   329501 | FOR                         |  |
| NEUROGENE INC.                   | 64135M105 | 06/12/2025     | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         162291 |                0 | FOR         |                                   162291 | FOR                         |  |
| NEUROGENE INC.                   | 64135M105 | 06/12/2025     | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         329501 |                0 | FOR         |                                   329501 | FOR                         |  |
| PLIANT THERAPEUTICS, INC.        | 729139105 | 06/05/2025     | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation.                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         280500 |                0 | ABSTAIN     |                                   280500 | AGAINST                     |  |
| PLIANT THERAPEUTICS, INC.        | 729139105 | 06/05/2025     | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation.                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         569500 |                0 | ABSTAIN     |                                   569500 | AGAINST                     |  |
| PLIANT THERAPEUTICS, INC.        | 729139105 | 06/05/2025     | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation.                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         280500 |                0 | ABSTAIN     |                                   280500 | AGAINST                     |  |
| PLIANT THERAPEUTICS, INC.        | 729139105 | 06/05/2025     | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation.                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         569500 |                0 | ABSTAIN     |                                   569500 | AGAINST                     |  |
| UROGEN PHARMA LTD                | M96088105 | 08/06/2024     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         834092 |                0 | FOR         |                                   834092 | FOR                         |  |
| UROGEN PHARMA LTD                | M96088105 | 08/06/2024     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        1211630 |                0 | FOR         |                                  1211630 | FOR                         |  |
| UROGEN PHARMA LTD                | M96088105 | 08/06/2024     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         834092 |                0 | FOR         |                                   834092 | FOR                         |  |
| UROGEN PHARMA LTD                | M96088105 | 08/06/2024     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        1211630 |                0 | FOR         |                                  1211630 | FOR                         |  |
| VAXCYTE, INC.                    | 92243G108 | 06/12/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          18321 |                0 | FOR         |                                    18321 | FOR                         |  |
| VAXCYTE, INC.                    | 92243G108 | 06/12/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          37196 |                0 | FOR         |                                    37196 | FOR                         |  |
| VAXCYTE, INC.                    | 92243G108 | 06/12/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          18321 |                0 | FOR         |                                    18321 | FOR                         |  |
| VAXCYTE, INC.                    | 92243G108 | 06/12/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          37196 |                0 | FOR         |                                    37196 | FOR                         |  |
| VISTAGEN THERAPEUTICS, INC.      | 92840H400 | 08/26/2024     | To approve, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers.                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         581148 |                0 | FOR         |                                   581148 | FOR                         |  |
| VISTAGEN THERAPEUTICS, INC.      | 92840H400 | 08/26/2024     | To approve, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers.                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         844195 |                0 | FOR         |                                   844195 | FOR                         |  |
| VISTAGEN THERAPEUTICS, INC.      | 92840H400 | 08/26/2024     | To approve, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers.                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         581148 |                0 | FOR         |                                   581148 | FOR                         |  |
| VISTAGEN THERAPEUTICS, INC.      | 92840H400 | 08/26/2024     | To approve, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers.                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         844195 |                0 | FOR         |                                   844195 | FOR                         |  |
| VOYAGER THERAPEUTICS, INC.       | 92915B106 | 06/03/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         206671 |                0 | FOR         |                                   206671 | FOR                         |  |
| VOYAGER THERAPEUTICS, INC.       | 92915B106 | 06/03/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         419604 |                0 | FOR         |                                   419604 | FOR                         |  |
| VOYAGER THERAPEUTICS, INC.       | 92915B106 | 06/03/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         206671 |                0 | FOR         |                                   206671 | FOR                         |  |
| VOYAGER THERAPEUTICS, INC.       | 92915B106 | 06/03/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         419604 |                0 | FOR         |                                   419604 | FOR                         |  |
| XENON PHARMACEUTICALS INC        | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers.                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          80940 |                0 | FOR         |                                    80940 | FOR                         |  |
| XENON PHARMACEUTICALS INC        | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers.                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         164332 |                0 | FOR         |                                   164332 | FOR                         |  |
| XENON PHARMACEUTICALS INC        | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers.                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          80940 |                0 | FOR         |                                    80940 | FOR                         |  |
| XENON PHARMACEUTICALS INC        | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers.                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         164332 |                0 | FOR         |                                   164332 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** GREAT POINT PARTNERS LLC

**By (Signature):** Dr. Jeffrey R. Jay, M.D.

**By (Printed Signature):** Dr. Jeffrey R. Jay, M.D.

**By (Title):** Senior Managing Member

**Date:** 08/29/2025